Evidence map›Paper›PMID 35521792›Full record

ArticleEuropean journal of endocrinology2022

Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism.

Treena Cranston, Hannah Boon, Mie K Olesen, Fiona J Ryan, Deborah Shears, Rosemary London, Hussam Rostom, Taha Elajnaf, Rajesh V Thakker, Fadil M Hannan

Open access · hybridAbstract read
In one paragraph

Article in European journal of endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Hypoparathyroidism: Similarities and differences between Western and Eastern countries.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Treena CranstonOxford Genetics Laboratories, Churchill Hospital, Oxford, UK.
Hannah BoonOxford Genetics Laboratories, Churchill Hospital, Oxford, UK.
Mie K OlesenAcademic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Fiona J RyanPaediatric Endocrinology, Children's Hospital, John Radcliffe Hospital, Oxford, UK.
Deborah ShearsOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford, UK.
Rosemary LondonPaediatric Endocrinology, Children's Hospital, John Radcliffe Hospital, Oxford, UK.
Hussam RostomNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Taha ElajnafNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Rajesh V ThakkerAcademic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Fadil M HannanNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-2975-5170
University of Oxford · GBChurchill Hospital · GBJohn Radcliffe Hospital · GBNational Institute for Health Research · GBNuffield Orthopaedic Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive disorder characterised by immune dysregulation and autoimmune endocrine gland destruction. APS-1 is caused by biallelic mutations affecting the autoimmune regulator (AIRE) gene on chromosome 21q22.3, which facilitates immunological self-tolerance. The objective was to investigate >300 probands with suspected APS-1 or isolated hypoparathyroidism for AIRE abnormalities. Methods: Probands were assessed by DNA sequence analysis. Novel variants were characterised using 3D modelling of the AIRE protein. Restriction enzyme and microsatellite analysis were used to investigate for uniparental isodisomy. Results: Biallelic AIRE mutations were identified in 35 probands with APS-1 and 5 probands with isolated hypoparathyroidism. These included a novel homozygous p.(His14Pro) mutation, predicted to disrupt the N-terminal caspase activation recruitment domain of the AIRE protein. Furthermore, an apparently homozygous AIRE mutation, p.Leu323fs, was identified in an APS-1 proband, who is the child of non-consanguineous asymptomatic parents. Microsatellite analysis revealed that the proband inherited two copies of the paternal mutant AIRE allele due to uniparental isodisomy. Hypoparathyroidism was the most common endocrine manifestation in AIRE mutation-positive probands and >45% of those harbouring AIRE mutations had at least two diseases out of the triad of candidiasis, hypoparathyroidism, and hypoadrenalism. In contrast, type 1 diabetes and hypothyroidism occurred more frequently in AIRE mutation-negative probands with suspected APS-1. Around 30% of AIRE mutation-negative probands with isolated hypoparathyroidism harboured mutations in other hypoparathyroid genes. Conclusions: This study of a large cohort referred for AIRE mutational analysis expands the spectrum of genetic abnormalities causing APS-1.

Indexed as

HypoparathyroidismPolyendocrinopathies, AutoimmuneAIRE ProteinChildGerm CellsHumansMutationTranscription FactorsUniparental DisomyAIRE ProteinTranscription Factors

Identifiers

PMID35521792
PMCPMC9175554
OpenAlexW4228998063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.